New drug aims to prevent lifelong lung damage in tiniest babies

NCT ID NCT06897839

Recruiting now Prevention Sponsor: Airway Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study tests an investigational drug called zelpultide alfa to see if it can prevent bronchopulmonary dysplasia (BPD) — a serious, chronic lung disease — in extremely premature infants (born between 22 and 27 weeks). About 366 babies who are on a breathing machine will receive either the drug or a sham treatment alongside standard care. The goal is to reduce the number of babies who develop severe BPD or die.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Azienda Ospedale Università di Padova
RECRUITING

Padova, Italy
Bnai Zion Medical Center
NOT_YET_RECRUITING

Haifa, Israel
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
NOT_YET_RECRUITING

Milan, Italy
Hospital Clínic de Barcelona
RECRUITING

Barcelona, Spain
Hospital Clínico Universitario de Santiago
RECRUITING

Santiago de Compostela, Spain
Hospital General Universitario Gregorio Marañón
NOT_YET_RECRUITING

Madrid, Spain
Hospital General Universitario de Alicante Dr. Balmis
RECRUITING

Alicante, Spain
Hospital Regional Universitario de Málaga
RECRUITING

Málaga, Spain
Hospital Sant Joan de Déu
RECRUITING

Barcelona, Spain
Hospital Universitari Arnau de Vilanova de Lleida
RECRUITING

Lleida, Spain
Hospital Universitari i Politècnic La Fe
RECRUITING

Valencia, Spain
Hospital Universitario Cruces - OSI Ezkerraldea-Enkarterri-Cruces
RECRUITING

Bilbao, Spain
Hospital Universitario La Paz
RECRUITING

Madrid, Spain
Hospital Universitario Miguel Servet
RECRUITING

Zaragoza, Spain
Hospital Universitario Puerta del Mar
RECRUITING

Cadiz, Spain
Hospital de la Santa Creu i Sant Pau
RECRUITING

Barcelona, Spain
IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola
RECRUITING

Bologna, Italy
Ospedale dei Bambini "V. Buzzi"
RECRUITING

Milan, Italy
Shaare-Zedek Medical Center
RECRUITING

Jerusalem, Israel
Ziv Medical Center
RECRUITING

Safed, Israel

Conditions

Explore the condition pages connected to this study.

BRONCHOPULMONARY DYSPLASIA